NCT07106151 Outpatient Recovery From Acute Kidney Injury Requiring Dialysis - 2
| NCT ID | NCT07106151 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | AKI |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-02-23 |
| Primary Completion | 2028-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-02-23 with a primary completion date of 2028-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Providing additional information to patients with acute kidney injury who continue dialysis after hospital discharge and to the accepting kidney doctor (nephrologist) who manages their dialysis may be feasible and beneficial. This study will pilot measuring the patient's residual kidney function at the time of discharge and communicating that result to the accepting nephrologist and the patient, along with information on recommended recovery monitoring frequency and criteria for consideration of a twice-weekly hemodialysis schedule.
Eligibility Criteria
Inclusion Criteria: * AKI-D (not ESKD, as determined by the clinical inpatient nephrology team) * Age ≥ 18 years * Planned for continued dialysis outside the acute hospital setting (at outpatient dialysis unit/SNF/LTACH, not planned transfer to another short-stay acute care hospital). Exclusion Criteria: * Pregnant * Prisoner * Unable to consent and no surrogate decision maker available * Clinical team declines to allow approach for study
Contact & Investigator
Ian E McCoy, MD, MS
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT07106151 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying AKI. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07106151 currently recruiting?
Yes, NCT07106151 is actively recruiting participants. Contact the research team at ian.mccoy@ucsf.edu for enrollment information.
Where is the NCT07106151 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT07106151 clinical trial?
NCT07106151 is sponsored by University of California, San Francisco. The principal investigator is Ian E McCoy, MD, MS at University of California, San Francisco. The trial plans to enroll 40 participants.